Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review

• 1 January 2001
• journal article
• review article
• Published by National Institute for Health and Care Research in Health Technology Assessment
• Vol. 5  (1) , 1-137
• https://doi.org/10.3310/hta5010

Abstract

Keywords

• COST EFFECTIVENESS
• ASSESSMENT VOLUME
• SYSTEMATIC REVIEW
• HEALTH TECHNOLOGY
• REVIEW HEALTH
• TECHNOLOGY ASSESSMENT
• ALZHEIMER'S DISEASE
• GALANTAMINE
• MARCH
• PUBLISHED

Funding Information

• Health Technology Assessment Programme (00/08/01)